Sector

All

Cyber

Digital Biology

Alternative

Energy

Other

Location

All

Americas

EMEA

APAC

Rest of World

Home > Portfolio > 10X Genomics

Location:

San Francisco, CA, USA

Initial Investment Date:

November 2011

Investment Status:

Exited

Changing the definition of sequencing

10X Genomics is changing the definition of sequencing by providing an innovative genomics platform that dramatically upgrades the capabilities of existing short read sequencers. The company does this through a combination of elegant microfluidics, chemistry, and bioinformatics. With the GemCode Platform, researchers can now find structural variants, haplotypes, and other valuable long range information while leveraging existing sequencing workflows.